Teva starts phase III trial for MS drug
Pharmaceutical Business Review - USA
By Sarah Routledge Teva Pharmaceutical Industries and Active Biotech are initiating a phase III program for laquinimod, a once-daily, orally administered ...
See all stories on this topic

Elan, Biogen Say Tysabri to Get FDA Review for Crohn's Disease
Bloomberg - USA
By Kristen Hallam May 29 (Bloomberg) -- Elan Corp. said two US Food and Drug Administration advisory committees will review its Tysabri multiple sclerosis ...
See all stories on this topic

Acorda Therapeutics Begins Second Phase 3 Clinical Trial of ...
PharmaLive.com (press release) - Newtown,PA,USA
Data collected in laboratory studies found that fampridine can improve the communication between damaged nerves, which may result in increased neurological ...
See all stories on this topic

Acorda Therapeutics Begins Second Phase 3 Clinical Trial of ...
Genetic Engineering News (press release) - New Rochelle,NY,USA
Acorda Therapeutics (Nasdaq: ACOR) announced today that it has begun a second Phase 3 clinical study of Fampridine-SR in multiple sclerosis (MS), ...
See all stories on this topic

Acorda Begins Fampridine Study
Forbes - NY,USA
Biotechnology company Acorda Therapeutics said Wednesday it started a late-stage study on Fampridine as a multiple sclerosis treatment. ...
See all stories on this topic